ScreenerHero

SCNI Scinai Immunotherapeutics Ltd.

NAS · US · Healthcare · Biotechnology · scinai.com
1.130USD-7.38%Mkt Cap: 1.53M $P/E: 0.04

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody plat…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.53M USD
Enterprise Value7.25M USD
Revenue (TTM)1.49M USD
Gross Profit-2.65M USD
Net Income (TTM)-8.31M USD
Revenue/Share2.80 USD
Last Price1.130 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees45
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.04
P/E (Forward)—
PEG—
EV/EBITDA-1.09
EV/Revenue4.87
P/S1.11
P/B0.11
EPS (TTM)28.07
EPS (Forward)—
52W Range
1.1200% of range16.30
52W High16.30 USD
52W Low1.120 USD
Profitability
Gross Margin-202.29%
Oper. Margin-466.52%
EBITDA Margin0.00%
Profit Margin-633.64%
ROE-102.52%
ROA-71.45%
Growth
Revenue Growth146.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.03M USD
CapEx (TTM)24.00K USD
FCF Margin-245.95%
FCF Yield-239.17%
Net Debt926.00K USD
Net Debt/EBITDA-0.14
Balance Sheet
Debt/Equity0.28
Current Ratio1.56
Quick Ratio1.22
Book Value/Sh10.71 USD
Cash/Share4.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.35M
Float488.73K
Insiders14.16%
Institutions3.33%
Short Interest
Short Ratio0.2d
Short % Float69.31%
Short % Out.66.65%
Shares Short451.63K
Short (prev mo.)7.03K
Technical
SMA 502.191 (-48.4%)
SMA 2005.118 (-77.9%)
Beta2.13
S&P 52W Chg15.78%
Avg Vol (30d)1.58M
Avg Vol (10d)181.03K
Technical Indicators
RSI (14)33.5
MACD-0.2985
MACD Signal-0.2706
MACD Hist.-0.0279
BB Upper2.222 USD
BB Middle1.599 USD
BB Lower0.9766 USD
BB Width77.88%
ATR (14)0.2506 USD
Vol Ratio (20d)0.02x